Icecure Medical Ltd [NASDAQ: ICCM] traded at a high on Tuesday, posting a 18.18 gain after which it closed the day’ session at $0.75.
The results of the trading session contributed to over 4675897 shares changing hands. Over the past one week, the price volatility of Icecure Medical Ltd stands at 14.08% while the volatility over the past one month is 9.95%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The market cap for ICCM stock reached $36.18 million, with 45.73 million shares outstanding and 22.26 million shares in the current float. Compared to the average trading volume of 418.70K shares, ICCM reached a trading volume of 4675897 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Icecure Medical Ltd [ICCM]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ICCM shares is $3.39 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ICCM stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
The Average True Range (ATR) for Icecure Medical Ltd is set at 0.07, with the Price to Sales ratio for ICCM stock in the period of the last 12 months amounting to 10.83. The Price to Book ratio for the last quarter was 3.52, with the Price to Cash per share for the same quarter was set at 0.22.
How has ICCM stock performed recently?
Icecure Medical Ltd [ICCM] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 22.90. With this latest performance, ICCM shares gained by 8.31% in over the last four-week period, additionally sinking by -43.26% over the last 6 months – not to mention a drop of -25.29% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ICCM stock in for the last two-week period is set at 60.65, with the RSI for the last a single of trading hit 70.35, and the three-weeks RSI is set at 54.20 for Icecure Medical Ltd [ICCM]. The present Moving Average for the last 50 days of trading for this stock 0.7182, while it was recorded at 0.6302 for the last single week of trading, and 1.0376 for the last 200 days.
Icecure Medical Ltd [ICCM]: Deeper insight into the fundamentals
Icecure Medical Ltd’s liquidity data is similarly interesting compelling, with a Quick Ratio of 2.54 and a Current Ratio set at 2.97.
Earnings analysis for Icecure Medical Ltd [ICCM]
With the latest financial reports released by the company, Icecure Medical Ltd posted -0.09/share EPS, while the average EPS was predicted by analysts to be reported at -0.09/share. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ICCM.
Insider trade positions for Icecure Medical Ltd [ICCM]
The top three institutional holders of ICCM stocks are: GEODE CAPITAL MANAGEMENT, LLC with ownership of 25560.0 shares, which is approximately 0.056%. HRT FINANCIAL LP, holding 18726.0 shares of the stock with an approximate value of $$22000.0 in ICCM stocks shares; and HRT FINANCIAL LP, currently with $$18300.0 in ICCM stock with ownership which is approximately 0.0334%.
